We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0R8H market cap is 291.05M. The company's latest EPS is EUR 0.2526 and P/E is 51.07.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 519.97M | 510.83M | 581.27M | 695.1M | 727.5M |
| Operating Income | 9.93M | 17.91M | 27.73M | 8.63M | 20.6M |
| Net Income | 3.37M | 8.69M | 20.1M | 9.52M | 5.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 438.45M | 441.34M | 457.07M | 661.64M | 657.5M |
| Total Liabilities | 332.36M | 327.15M | 334.46M | 538.75M | 512.9M |
| Total Equity | 106.08M | 114.19M | 122.61M | 122.89M | 144.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 36.84M | 46.9M | 56.94M | 64.88M | 79M |
| Investing | -19.45M | -4.12M | -32.06M | -83.44M | -18.5M |
| Financing | -26.7M | -56.48M | -33.92M | 27.43M | -49.2M |
| Market Cap | 291.05M |
| Price to Earnings Ratio | 51.07 |
| Price to Sales Ratio | 0.4 |
| Price to Cash Ratio | 11.88 |
| Price to Book Ratio | 2.01 |
| Dividend Yield | - |
| Shares Outstanding | 22.56M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 12.90 |
| 52 Week Low | 12.90 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Pihlajalinna Oyj |
| Address |
kehrasaari b, 4th floor tampere 33200 |
| Website | https://www.pihlajalinna.fi |
| Industry | offices of medical doctors (8011) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
